NEW YORK , May 12, 2025 /PRNewswire/ -- Genpact (NYSE: G), an advanced technology services and solutions company, today announced it has been recognized as a Leader in the 2025 ISG Provider Lens™ for ServiceNow Ecosystem Partners in the United States. The ISG report highlights Genpact's innovative approach to deploying ServiceNow solutions to transform business operations, enhance efficiency, and drive enterprise-wide value.

FRAMINGHAM, Mass. & CORK, Ireland--(BUSINESS WIRE)--Ameresco, Inc., (NYSE: AMRC), a leading energy solutions provider dedicated to helping customers navigate the energy transition, today announced that its Irish subsidiary, Cork Sustainable Energy Limited (CSEL), has secured approval from An Bord Pleanála for a significant upgrade to the Kilvinane Wind Farm. This approval marks a pivotal step in enhancing Ireland's renewable energy infrastructure. CSEL manages Kilvinane Wind Farm, located 8km E.

New card incentivizes good financial practice via a suite of competitive features PITTSBURGH , May 12, 2025 /PRNewswire/ -- PNC Bank announced today the launch of its latest credit card, PNC Spend Wise℠ Visa® , designed to reward clients' responsible and healthy financial habits. This unique credit card is built to encourage responsible financial management through its associated purchase APR reduction program for eligible cardholders who meet timely payment and spend requirements.

STOUGHTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has entered into an Accelerated Share Repurchase ("ASR") agreement with Jefferies LLC to repurchase $25 million of the Company's common stock. Collegium will execute the ASR as part of the $150 million share repurchase program authorized by its Board of Directors in January 2024. Upon completion of this ASR, Collegium will have $65 million remaining under the program.

Microsoft invested $1 billion in OpenAI in 2019 and entered in a multi-year deal.

NN, Inc. (NASDAQ:NNBR ) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Harold Bevis - President and CEO Chris Bohnert - SVP & CFO Tim French - SVP & COO Stephen Poe - IR Conference Call Participants Robert Brown - Lake Street Capital Hans Baldau - Noble Capital Markets John Franzreb - Sidoti & Company Operator Good day and welcome to the NN Inc. first quarter 2025 earnings conference call. All participants will be in a listen-only mode.

John D'Agostino, Coinbase Institutional head of strategy, joins 'Squawk Box' to discuss the latest bitcoin price trends, the comparison to gold vs. Nasdaq, state of cryptocurrency at large, regulation around crypto, and more.

WILMINGTON, Del. , May 12, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its first quarter 2025 financial results after the market closes on Thursday, May 15, 2025 via press release, which will be available on the Company's website at https://ir.nrxpharma.com/.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

The company reported a year-over-year decline for the 4th fiscal quarter; however, the decline was less than expected, and sequential growth is expected in fiscal Q1 2025, and the odds are high that guidance is cautious.

AVENTURA, Fla.--(BUSINESS WIRE)--Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a leading provider of artificial intelligence (AI)-driven security solutions, announced today that its ballistics protection unit, Safe-Pro USA LLC has received an order for its American-made Explosive Ordnance Disposal (EOD) protective gear from a US Government Contractor (the “Contractor” or the “Customer”) operating in the Asia-Pacific region. Additionally, the Customer will test the Company's.

AUSTIN, Texas--(BUSINESS WIRE)---- $AMD #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, is pleased to announce today new benchmarking results that validate the accuracy and utility of its in silico epitope mapping application, part of the LENSai™ platform, with a direct comparison to gold-standard wet-lab methods. The results represent a notable advancement in computational biology, particularly in the field of antibody discovery, where high failure rates and cos.

FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that dosing of drug has completed in 90-day oral toxicity and toxicokinetic studies for Lucid-21-302 (Lucid-MS) for Multiple Sclerosis (“MS”). These studies were commissioned to provide data to support an IND application with the US FDA.

Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial, demonstrating proof-of-concept for neflamapimod as a potential treatment for dementia with Lewy bodies (DLB)

WARREN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN). As the biopharma industry faces increasing competition from international markets and an evolving regulatory landscape, Tevogen Bio's innovative business model positions it as a potential leader in the shift towards cost-efficient, value-driven healthcare.

Unlocking the potential of digital assets for institutions and fueling Amber International's strategic expansion SINGAPORE , May 12, 2025 /PRNewswire/ -- Amber International Holding Limited (Nasdaq: AMBR) ("Amber International", "AMBR", "we", "us", or the "Company"), a leading provider of institutional crypto financial services and operating under the brand name "Amber Premium", today announced the launch of its upsized crypto ecosystem reserve plan of US$100 million. The strategic treasury reserve initiative is designed to accelerate the Company's expansion and cement its leadership at the intersection of traditional and decentralized finance.

Innovative pilot project highlights the role of thermal energy storage in decarbonizing public institutions Pilot installations offer replicable frameworks for wider adoption Brenmiller's bGen™ intended to reduce 550 metric tons of CO2 emissions annually The project and its key findings will be presented in a webinar on May 19, 2025 hosted by the Renewable Thermal Collaborative TEL AVIV, IL / ACCESS Newswire / May 12, 2025 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq:BNRG), a leading global provider of thermal energy storage ("TES") solutions for industrial and utility customers, announced today the publication of a joint case …

~ Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for abuse and overdose, today announced it has added Tracy Hysong, CCRA as Senior Director of Regulatory Affairs to its management team. Ms. Hysong is a Certified Clinical Research Associate (CCRA) through the Association of Clinical Research Professionals with years of experience undertaking regulatory activity at the University of California Davis (UC Davis).

Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today addresses frequently asked stockholder questions regarding a reverse stock split proposal at the Company's Annual Meeting taking place on Wednesday, May 21, 2025, to regain Nasdaq compliance.